Part IV of VI

The Science of Peptides

What they are, how they work, and why the mouth is an unusually good target

Peptides have arrived in public conversation wrapped in biohacking vocabulary. Part IV strips that away and explains what they are, how they differ from drugs, and why the mouth is an unusually good place to think about them.

Peptides are short chains of amino acids that act as signals, telling tissue what to do rather than doing the work themselves. The book compares them with something most patients have already received without noticing: compounded local anesthetics and custom preparations that reach dental offices through the same compounding pathway.

Four compounds are examined one at a time, each with mechanism, evidence and limits stated plainly: BPC-157, GHK-Cu, TB-500 and KPV. The chapter is organized around the questions that come up when a decision actually has to be made.

The mouth suits this class of therapy for physical reasons: rich blood supply, direct access, fast tissue turnover, and the possibility of delivering treatment locally rather than throughout the body. This is the most technical section of the book and the most carefully hedged.

Chapters in this part

What Are Peptides? A Primer

Signaling molecules versus drugs, and where peptides sit in the regulatory landscape.

The Peptides That Matter Most for Your Mouth

BPC-157, GHK-Cu, TB-500 and KPV: mechanism, evidence and honest limits.

The Oral Environment as a Peptide Target

Vascularity, accessibility, turnover and local delivery: why the mouth is unusually well suited.

Interactive

Where a peptide sits

Between a single amino acid and a full protein.

Amino acid

One building block.

Peptide

Roughly 2 to 50 linked: long enough to carry a specific signal, short enough to act quickly and locally.

Protein

More than 50, folded into working machinery.

Evidence standard

What the evidence supports

Peptides are biologically active signaling molecules with plausible, studied mechanisms.
The mouth's anatomy favors local delivery.
Compounding is an established pathway in dentistry.

Where the book draws the line

Much of the peptide evidence is preclinical. Where dental trials do not exist, the book says so every time.
Regulatory status changes; nothing here claims a compound is available or permitted.
No dosing guidance appears in the book or on this site.

A note on regulatory status. The status of several compounds discussed in Part IV has changed more than once since 2023 and is still moving. The book opens this section with a dated standing note for that reason. Check where any compound stands on the day you read this, with a licensed clinician and the FDA's current list²⁶.

All references →